Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can talking therapy help picky eaters? new study tests CBT for ARFID

NCT ID NCT05954728

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested two treatments for avoidant/restrictive food intake disorder (ARFID) in 53 children and teens aged 10-18. One group received cognitive-behavioral therapy (CBT-AR) and the other received nutrition counseling. The goal was to see which approach better reduces fear of new foods and improves eating habits. Researchers also used brain scans to understand how the treatments work.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
cognitive-behavioral therapy (CBT-AR) and nutrition counseling
What this could lead to
If successful, this could show that CBT-AR is an effective treatment to help children and teens with ARFID eat a wider variety of foods.
What could go wrong
This is a small, early-stage study with only 53 participants, so results may not apply to everyone. The therapy requires time and commitment, and not all participants may benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

53 people

The number who actually took part.

Started

Jan 2024

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

10 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Males and Females ages 10-18 years old * Current ARFID * Normal TSH or free T4 levels to rule out thyroid disease as cause of symptoms * Negative celiac screening panel indicating no active celiac disease as cause of symptoms * Fluency and literacy in English Exclusion Criteria: * BMI \< 5th percentile for sex and age * Pregnancy, breastfeeding, or recent initiation/cessation of oral contraceptive pills within 8 weeks of the pre-treatment study visit * Current/history of psychosis * Substance/alcohol use disorder (active within the past month) * Medical instability requiring inpatient care according to the American Psychiatric Association 2023 treatment guidelines for eating disorders * Laboratory abnormalities indicating a need for higher level of care * Complete lack of oral intake (suggesting a need for inpatient care) * Tube feeding (suggesting a need for tube weaning) * Active suicidal/homicidal ideation with intent or plan * Contraindications to MRI * History of major gastrointestinal tract surgery or serious medical condition (e.g., cancer) * Medical history of intellectual disability * Illiteracy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Avoidant/restrictive food intake disorder (arfid) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Eating Disorders Clinical and Research Program

    Boston, Massachusetts, 02139, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.